本科畢業(yè)于中山醫(yī)科大學(xué)，2005年獲得北京大學(xué)醫(yī)學(xué)部腫瘤學(xué)博士學(xué)位，胸部腫瘤內(nèi)一科  主任醫(yī)師，副教授，科室副主任，內(nèi)科教研室常務(wù)副主任。CSCO青年專家委員會肺癌專業(yè)組委員、CSCO會員、ASCO會員。，2010年赴美國馬里蘭大學(xué)接受博士后培訓(xùn)兩年，開展新型抗體治療的臨床前期動物模型研究以及腫瘤分子生物學(xué)和肺癌個體化治療的學(xué)習(xí)。目前主要從事肺癌多學(xué)科綜合治療，擅長肺癌、胸腺癌、胸膜間皮瘤等胸部腫瘤的早期診斷、以內(nèi)科化療為主的綜合規(guī)范化治療、分子靶向治療及生物治療，對生物標(biāo)志物指導(dǎo)下的肺癌個體化治療有深入研究，熟練掌握肺癌的最新國際診療規(guī)范，參加20余項國際、國內(nèi)多中心臨床研究，及時掌握國際肺癌診治前沿新動向。

專業(yè)特長

從事腫瘤臨床工作近14年，在胸部腫瘤尤其是肺癌的多學(xué)科綜合治療上有豐富經(jīng)驗及深厚的學(xué)術(shù)造詣，擅長肺癌早期診斷以及規(guī)范化、個體化多學(xué)科綜合治療及氣管鏡、TBNA、內(nèi)科胸腔鏡等局部治療及操作。

研究成果

2008年獲得北京腫瘤醫(yī)院北京市腫瘤防治研究所所內(nèi)基金，先后獲得教育部科技成果二等獎、華夏科技成果二等獎及北京市科技進(jìn)步三等獎、中華醫(yī)學(xué)獎三等獎等獎勵。

主要論著

1) MeinaWua, Jun Zhao(equal contribution）, SonyaWei Song, Minglei Zhuo, XinWang, Hua Bai, ShuhangWanga, Lu Yang, Tongtong An, Yan Zhang, Jianchun Duan, YuyanWang, Qingzhi Guo,Xuyi Liu, Ninghong Liu, JieWang. Plasma EGFR mutations are not associated with response to first-line chemotherapy but with prognosis in the Chinese patients with advanced non-small cell lung cancer. lung cancer 2010, 67(3):343-347

2) Jun Zhao, Zhi-jie Wang, Jian-chun Duan, Qing-zhi Guo, Hua Bai, Lu Yang, Tong-tong An, Xin Wang, Yu-yan Wang and Mei-na Wu, et al. A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression. Chinese journal of cancer research, 2009，21(1)： 1-12.

3) Xin Wang, Jun Zhao, Lu Yang, Li Mao,Tongtong An, Hua Bai,Shuhang Wang ,Xuyi Liu,Guo shuang Feng, Jie Wang. Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer.  Med Oncol  2010,27(2):484-490

4) Hua Bai, Zhijie Wang, Keneng Chen, Jun Zhao, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang1, Xiaozheng Kang, Jie Wang. Influence of Chemotherapy on EGFR Mutation Status for Patients with Non-small Cell Lung Cancer. J Clin Oncol，2012

5) Shuhang Wang, Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, and Meina Wu.Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced NSCLC. Clin Cancer Res 2010, 15,16(4):1324-1330

6) 趙軍，劉敘儀，張青云，蔣薇。晚期非小細(xì)胞肺癌外周血VEGF和BFGF及MMP-9水平與預(yù)后的關(guān)系。中華腫瘤雜志 2005; 27: 676-679

7) 白樺,趙軍,王書航,安彤同,王鑫,吳梅娜,段建春,楊鷺,郭慶志,劉寧紅,王潔.變性高效液相色譜法檢測非小細(xì)胞肺癌人群外周血和配對腫瘤組織EGFR突變。中華結(jié)核和呼吸雜志，2008，31：891-896

8) Wu M, Wang Y, An T, Zhao J, Yang L, Duan J, Wang Z, Zhuo M, Bai H, Liu X, Wang J. Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer. Zhong guo Fei Ai Za Zhi. 2011 Mar;14(3):245-50

9) Wang Z, Yang L, An T, Zhao J, Bai H, Duan J, Wu M, Zhou M, Wang Y, Wang J. The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis. Zhong guo Fei Ai Za Zhi. 2009 Dec 20;12(12):1247-54.

10) Yang L, Lu QY, Wu MN, An TT, Zhao J, Guo QZ, Duan JC, Wang J. A retrospective analysis: comparison of the clinical characteristics and prognosis in elderly and young patients with locally advanced or metastatic non-small cell lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):830-4.

11) Wang J, Lu C, Liu XY, Zhang HB, Zhao J, Yang L, Guo QZ, An TT, Wu MN. Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):103-7